Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Shares Outstanding (Diluted Average) (2016 - 2017)

Historic Shares Outstanding (Diluted Average) for AC Immune (ACIU) over the last 4 years, with Q3 2019 value amounting to $0.93.

  • AC Immune's Shares Outstanding (Diluted Average) changed N/A to $0.93 in Q3 2019 from the same period last year, while for Sep 2019 it was $0.93, marking a year-over-year change of. This contributed to the annual value of $57.9 million for FY2017, which is 1549.24% up from last year.
  • According to the latest figures from Q3 2019, AC Immune's Shares Outstanding (Diluted Average) is $0.93.
  • AC Immune's Shares Outstanding (Diluted Average)'s 5-year high stood at $57.9 million during Q4 2017, with a 5-year trough of $0.67 in Q2 2019.
  • In the last 4 years, AC Immune's Shares Outstanding (Diluted Average) had a median value of $23.4 million in 2015 and averaged $25.8 million.
  • As far as peak fluctuations go, AC Immune's Shares Outstanding (Diluted Average) soared by 767.27% in 2016, and later skyrocketed by 1549.24% in 2017.
  • Over the past 4 years, AC Immune's Shares Outstanding (Diluted Average) (Quarter) stood at $46.5 million in 2015, then increased by 7.67% to $50.1 million in 2016, then grew by 15.49% to $57.9 million in 2017, then tumbled by 100.0% to $0.93 in 2019.
  • Its last three reported values are $0.93 in Q3 2019, $0.67 for Q2 2019, and $57.9 million during Q4 2017.